ÂÜÀòÂÒÂ×

Claudia Canzonetta is currently the Head of Pre-Clinical Development at Amplo Biotechnology, overseeing the planning and execution of pre-clinical studies across various indications and locations while facilitating data communication with cross-functional teams and the scientific community. Previously, Claudia served as SBIR Coordinator and Senior Project Consultant at Alien Technology Transfer, focusing on developing R&D proposals and business feasibility reports for small businesses in diverse technology areas, including drug development and medical devices. Claudia's earlier roles include Research Fellow at Ospedale Pediatrico Bambino Gesù, where research centered on Neuroblastoma, and as a Research Fellow at multiple institutions, including University of Rome "La Sapienza" and Queen Mary University, investigating various aspects of biology and biotechnology. Claudia holds a Ph.D. in Molecular Biology from Imperial College London and a Laurea in Chemistry from Sapienza Università di Roma.